Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.86 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | PRKCA | P17252 | 5/20 | 0.49 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16046795 | 1.00 | NAAA (0.86) | NAAADGKALMNAPRKCAPAM | |
| SCHEMBL1457470 | 1.00 | NAAA (0.86) | NAAADGKALMNAPRKCAPAM | |
| SCHEMBL30915389 | 1.00 | NAAA (0.86) | NAAADGKALMNAPRKCAPAM | |
| SCHEMBL28110502 | 1.00 | NAAA (0.86) | NAAADGKALMNAPRKCAPAM | |
| SCHEMBL27913647 | 1.00 | NAAA (0.86) | NAAADGKALMNAPRKCAPAM | |
| SCHEMBL4978268 | 0.98 | NAAA (0.82) | NAAADGKALMNAPRKCAPAM | |
| SCHEMBL3654640 | 0.92 | NAAA (1.00) | NAAADGKALMNAPRKCASMN1; SMN2 | |
| SCHEMBL9800900 | 0.92 | NAAA (1.00) | NAAADGKALMNAPRKCASMN1; SMN2 | |
| SCHEMBL3660392 | 0.92 | NAAA (1.00) | NAAADGKALMNAPRKCASMN1; SMN2 | |
| SCHEMBL1456468 | 0.92 | NAAA (1.00) | NAAADGKALMNAPRKCASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592418-B1 | USE OF ENDOCANNABINOID-LIKE COMPOUNDS FOR TREATING CNS DEGENERATIVE DISORDERS | RES & INNOVATION S P A (IT) | 2017-09-06 | — | — | EP | disclosed |
| EP-1900365-B9 | Endocannabinoid-like compounds and their use for treating dermatitis | RES & INNOVATION S P A (IT) | 2012-01-18 | — | — | EP | disclosed |
| EP-1900365-B1 | Endocannabinoid-like compounds and their use for treating dermatitis | RES & INNOVATION S P A (IT) | 2011-03-30 | — | — | EP | disclosed |
| EP-1900365-A2 | New endocannabinoid-like compounds and their use | RESEARCH & INNOVATION SOC. COOP. A R.L. (IT) | 2008-03-19 | — | — | EP | disclosed |
| EP-1592418-A2 | USE IN THERAPY OF ENDOCANNABINOID-LIKE COMPOUNDS | Research & Innovation Soc. Coop. A R.L. (IT) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004069240-A2 | USE IN THERAPY OF ENDOCANNABINOID-LIKE COMPOUNDS | RESEARCH & INNOVATION SOC. COOP. A. R. L. (IT) | 2004-08-19 | — | — | WO | disclosed |